We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SMALL BIOTECH FIRMS WANTS MORE CBER GUIDANCE
SMALL BIOTECH FIRMS WANTS MORE CBER GUIDANCE
April 16, 2004
The biotechnology industry has a tremendous hunger for more FDA guidance on how to navigate the drug approval process for biological products, according to an industry attorney.